Speaker
Senior Vice President, Research & Development, RION Health Inc
Christopher Paradise, Senior Vice President, Research & Development at RION Health Inc, spoke at 8th Exosome-Based Therapeutics Development Summit (Boston, United States of America, 22–24 Sept 2026) in the session “Defining Potency Assays for Exosome Therapeutics to Link Mechanism of Action to Measurable Biological Activity & Better Understand Product CQAs”.
22–24 Sept 2026Boston, United States of America
Chief Technology Officer, Gefjon Pharma
Research & Development Director, Neucore Bio
Hemato-Oncologist, Centro Oncologico de Antioquia
Chief Commercial Officer, NorthX Biologics
Chief Executive Officer, Aegle Therapeutics
R&D Director, NurExone
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Christopher Paradise, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].